D. E. Shaw & Co., Inc. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$4,031,744
-25.0%
316,961
-17.0%
0.00%
-20.0%
Q2 2023$5,375,913
-56.0%
381,812
-51.7%
0.01%
-61.5%
Q1 2023$12,217,644
-25.3%
790,786
-20.8%
0.01%
-27.8%
Q4 2022$16,365,300
+11.9%
998,493
+26.3%
0.02%
+5.9%
Q3 2022$14,623,000
+566.2%
790,411
+373.6%
0.02%
+466.7%
Q2 2022$2,195,000
+270.8%
166,885
+161.2%
0.00%
+200.0%
Q1 2022$592,000
-59.6%
63,894
-57.4%
0.00%0.0%
Q4 2021$1,465,000
+330.9%
149,908
+1399.1%
0.00%
Q3 2021$340,000
-7.1%
10,0000.0%0.00%
Q2 2021$366,000
-18.3%
10,0000.0%0.00%
Q1 2021$448,000
-70.9%
10,000
-62.9%
0.00%
-100.0%
Q4 2020$1,538,000
-3.3%
26,943
-13.1%
0.00%
-33.3%
Q3 2020$1,591,000
-14.1%
31,022
-0.0%
0.00%
+50.0%
Q2 2020$1,853,000
+349.8%
31,025
+210.2%
0.00%
+100.0%
Q1 2020$412,000
-50.4%
10,000
-25.1%
0.00%0.0%
Q4 2019$831,000
-35.0%
13,351
-64.6%
0.00%
-50.0%
Q3 2019$1,279,000
+252.3%
37,689
+308.3%
0.00%
Q2 2018$363,0009,2310.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q2 2020
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$18,687,87215.44%
Redmile Group, LLC 5,582,105$86,243,5223.74%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,218,638$80,627,9571.80%
BRAIDWELL LP 3,241,351$50,078,8731.65%
Parkman Healthcare Partners LLC 491,772$7,597,8771.65%
Sunesis Advisors, LLC 96,299$1,487,8201.07%
ARMISTICE CAPITAL, LLC 4,100,000$63,345,0000.91%
Deep Track Capital, LP 1,363,201$21,061,4550.86%
AlphaCentric Advisors LLC 72,500$1,120,1250.77%
Ikarian Capital, LLC 174,510$2,696,1790.61%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders